CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.
Standard
CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity. / Ganzer, S; Arlt, Sönke; Schoder, V; Buhmann, Carsten; Mandelkow, E-M; Finckh, U; Beisiegel, U; Naber, Dieter; Müller-Thomsen, T.
In: J NEURAL TRANSM, Vol. 110, No. 10, 10, 2003, p. 1149-1160.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.
AU - Ganzer, S
AU - Arlt, Sönke
AU - Schoder, V
AU - Buhmann, Carsten
AU - Mandelkow, E-M
AU - Finckh, U
AU - Beisiegel, U
AU - Naber, Dieter
AU - Müller-Thomsen, T
PY - 2003
Y1 - 2003
N2 - This study evaluated the sensitivity and specificity of the cerebrospinal fluid (CSF) levels of tau-protein, amyloid-beta-peptide 1-42 (Abeta1-42), ApoE-genotype and the degree of cognitive decline as diagnostic markers for Alzheimer's disease (AD). Data was obtained from 105 AD patients and 68 controls. Median CSF-tau levels were increased (512 pg/ml vs. 145 pg/ml, p
AB - This study evaluated the sensitivity and specificity of the cerebrospinal fluid (CSF) levels of tau-protein, amyloid-beta-peptide 1-42 (Abeta1-42), ApoE-genotype and the degree of cognitive decline as diagnostic markers for Alzheimer's disease (AD). Data was obtained from 105 AD patients and 68 controls. Median CSF-tau levels were increased (512 pg/ml vs. 145 pg/ml, p
M3 - SCORING: Zeitschriftenaufsatz
VL - 110
SP - 1149
EP - 1160
JO - J NEURAL TRANSM
JF - J NEURAL TRANSM
SN - 0300-9564
IS - 10
M1 - 10
ER -